Share Name Share Symbol Market Type Share ISIN Share Description
Summit Corporation LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +3.50p +2.09% 171.00p 167.00p 175.00p 172.50p 167.50p 167.50p 14,120 14:54:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.3 -25.7 -35.0 - 105.90

Summit Corp Share Discussion Threads

Showing 39051 to 39074 of 39075 messages
Chat Pages: 1563  1562  1561  1560  1559  1558  1557  1556  1555  1554  1553  1552  Older
DateSubjectAuthorDiscuss
20/11/2017
16:54
Looking perky over there! $11.63 at the moment.
waterloo01
20/11/2017
12:15
Todays RNS must surely be good news as it shows once again Summit are on track for their DMD roll out & that there were no complications. hTTp://otp.investis.com/clients/uk/summit_corporation_plc/rns/regulatory-story.aspx?cid=1575&newsid=951345
chrisatrdg
17/11/2017
19:49
Action Duchenne launches new Research Strategy for Duchenne muscular dystrophy link below: hTTp://www.actionduchenne.org/wp-content/uploads/2017/11/Action-Duchenne-Research-Strategy_Web.pdf The report mentions Summit as part of many other scientific options which shows how much there is for analysts to absorb.
chrisatrdg
17/11/2017
17:42
And up she goes as we close. Just a gut feeling but do suspect the 2nd broker is about the end game here (having recently raised along with milestones fromSRPT and the $30m + from Barda, they are cashed up) so IF anything behind it, it's 'corporate'.
waterloo01
16/11/2017
22:49
The second broker is very proud of their deal making, whether big or small. Https://www.panmure.com/about-us/recent-transactions/
luminoso
16/11/2017
21:39
Summit tweet this evening: Summit Therapeutics‏ @Summitplc 1h1 hour ago Summit Therapeutics Retweeted Duchenne UK Proud to be involved with such an important initiative for those living #Duchenne!Summit Therapeutics added, Duchenne UK Verified account @DuchenneUK Duchenne UK launches Project HERCULES to help patients get faster access to potentially life-changing treatments... hxxp://fb.me/zFFZKy3f 0 replies 0 retweets 0 likes
chrisatrdg
16/11/2017
21:34
Well waterloo01 if you think there is 'something afoot' with the 2nd broker it also supports my view that you could be right or its simply all for administration purposes or something similar. My question is what can a second broker do that the first cannot do or is one to cover the US & the other UK in other words why is the second broker something to start us all thinking why?
chrisatrdg
16/11/2017
21:07
Who's "Sue What" Waterloo and where does she come into the picture?
algernon2
16/11/2017
19:52
Somethings afoot with the 2nd broker on AIM, just not sue what!
waterloo01
16/11/2017
15:04
I agree with your comment Hyper A1 about 'very unstable times ahead' & last night I attended a presentation at Regents University London being an 'iCES and Senior European Experts Seminar' title 'Europe After the Shocks'.During the discussion it was suggested that there were 'fears of a total melt down' in the UK 'politically & economicaly'in the near future.Watch this space.
chrisatrdg
16/11/2017
14:08
I agree, chris. FWIW, I think it makes sense for DMD to be sold off to Sarepta, who with their contacts, lobbyists, and financial clout will get it approved so much more quickly. With that money, the C.Diff programme could be progressed in house I can't see many major shareholders standing in the way of DMD being sold off, if the price was right. I am still wondering what else Sarepta could have in mind for the proceeds of their recent fundraising.
luminoso
16/11/2017
13:26
Hi luminoso - My post this morning is a result of comments on this board & 'the other board' plus conversations with people on this board & 'the other board' at various recent AGM's.It is all conjecture but I sense that something is brewing.
chrisatrdg
16/11/2017
13:22
Summit tweet today: It's World #AntibioticAwarenessWeek! While #Cdiff is not yet affected by #AntibioticResistance, the use of vancomycin and metronidazole to treat C. diff could drive resistance for other bacteria. Precision antibiotics like ridinilazole are in need!
chrisatrdg
16/11/2017
13:19
interesting, chris. Where are these hunches coming from ?
luminoso
16/11/2017
12:34
Todays RNS Following up on this mornings posts it appears that something is happening but not sure what I had a sense that the US side is pulling away on DMD to be fed by Summit (Oxford) Ltd (subsidiary of the plc) & is the operating company of the group.With US side being DMD it would then lead Summit in the UK to continue with C-Diff.However I am not sure it is likely as my understanding is that the principle investors in Summit wanted to see DMD through to production.It is all speculation maybe the next quarters accounts in late November or December may shed further light on where we are.
chrisatrdg
16/11/2017
09:53
Perhaps an effort to make the shareprice "high"... ;)
phowdo
16/11/2017
09:36
Anyone care to comment on the significance of having a "joint" broker?
hugus maximus
16/11/2017
09:09
Anything to be made of that news?
makingmillions
13/11/2017
19:12
Thanks Dalcon01 ... "The conference brings together families living with Duchenne and Becker muscular dystrophy, along with experts and industry members aiming to treat these diseases." So this conference also involves Becker Muscular Dystrophy. I remember an AGM a few years ago when the subject arose of whether the same approach with Utrophin modulation might indeed work with Becker MD? At the time, there was very much a modus operandi, focusing resources on the principle of proving a fix for Duchenne, however I assume that if EZT is shown to work with Duchenne, there's no reason why Becker MD(which has approximately the same number of sufferers world wide)shouldn't be looked at with the same treatment? Please someone correct me if I'm wrong, but I've not read anything that suggest's Sarepta's Exondys 51 holds a potential way forward for Becker MD?
hugus maximus
13/11/2017
18:44
Apologies if you've seen this but just seen it on a new thread that's been opened? arnu gutierrez   12 Nov '17 - 02:48   0   0 Summit Therapeutics Sees Utrophin Modulation as a Potential Universal Treatment Option in Duchenne muscular dystrophy http://crweworld.com/article/news-provided-by-globenewswire/173671/summit-highlights-utrophin-modulation-as-a-potential-universal-treatment-option-in-dmd-at-15th-action-duchenne-international-conference
dalcon01
13/11/2017
17:42
Per gmcc this evening from the other board: 'DMD utrophin FYI : hTTps://laforcedmd.com/portrait-duchenne-utrophin-modulator/ For folks who have not come across utrophin modulators nice simple explanation ! £Michelle Avery, PhD Director, Investor Relations at Summit Therapeutics plc Dated 28/10/2017 £R: It is very exciting work. We are hoping this is, like, the first trial that lets us know whether or not this has a chance to work in patients, and we are really, really hopefull It seems like it makes sense from a scientific perspective. Good luck DMD community'
chrisatrdg
13/11/2017
16:19
Volume and price looking good on Nasdaq. Will it shoot through $12.00 or is that resistance?
waterloo01
13/11/2017
11:20
Morning Chris - IMO - any conjecture here could also be fuelled by the fact that if EZT proves to be a success next year, Sarepta in their current agreement have to stump up a further $500M in part payments .. simply in order to maintain the EU rights! By comparison a deal now, whilst Summit's share price is so low would be daylight robbery.
hugus maximus
13/11/2017
10:12
Good start to the day lets hope the share price will increase further but it still has a long way to go before getting back to where we were. Interesting posts recently on why Serepta is increasing what is seen as a 'war chest' not sure they will go for a Buy for Summit as I think they already have what they want from us for now.
chrisatrdg
Chat Pages: 1563  1562  1561  1560  1559  1558  1557  1556  1555  1554  1553  1552  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20171120 17:36:07